Author:
Cornall Alyssa M.,Poljak Marin,Garland Suzanne M.,Phillips Samuel,Machalek Dorothy A.,Tan Jeffrey H.,Quinn Michael A.,Tabrizi Sepehr N.
Funder
Royal Women's Hospital Human Research and Ethics Committees
Subject
Infectious Diseases,Virology
Reference37 articles.
1. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study;Dillner;Br. Med. J.,2008
2. Pathogenic role of the eight probably/possibly carcinogenic HPV types 26, 53, 66, 67, 68, 70, 73 and 82 in cervical cancer;Halec;J. Pathol.,2014
3. Human papilloma virus type 69 identified in a clinically aggressive plantar verruca from an HIV-positive patient;Whitaker;J. Am. Podiatr. Med. Assoc.,2009
4. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions;FUTURE II Study Group;N. Engl. J. Med.,2007
5. Evaluation of human papillomavirus type replacement post-vaccination must account for diagnostic artifacts: masking of HPV52 by HPV16 in anogenital specimens;Tota;Cancer Epidemiol. Biomark. Prev.,2015